Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)

NCT07243262 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT07243262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07243262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Recruiting
Start date
October 21, 2025
Completion date
August 1, 2028
Enrollment
6,079 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer, pdac - pancreatic ductal adenocarcinoma